Dose reduction of IL-17 and IL-23 inhibitors is safe and effective for patients with psoriasis and stable low disease activity.
There is a dose-response relationship between physical activity and rapid kidney function decline in older adults, according to a study published online Feb. 11 in the Journal of the American Society ...
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in doses of 100,000 IU every two weeks significantly reduced disease activity ...
High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) in the ...
Low dose (metronomic) chemotherapy is a condensed, lower dose form of chemotherapy that is given on a more frequent schedule than traditional regimens. Traditional chemotherapies are usually given at ...
LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today shared new data ...
First-in-human clinical, pharmacokinetic (PK), and pharmacodynamic (PD) phase I study of the first-in-class spliceosome inhibitor E7107 administered IV (bolus) on days 1, 8, and 15 every 28 days to ...
Zoloft (sertraline), is prescribed for various mental health conditions. It is available in oral tablet and liquid solution forms. Dosing of Zoloft varies by condition and other factors, with dosage ...
The MUSETTE trial found no additional benefit in higher doses of ocrelizumab for RMS compared to the standard 600 mg dose. The 600 mg dose of ocrelizumab remains optimal for slowing disability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results